Newborn screening tests is done to check the developmental, genetic, and metabolic disorders in the newborn baby. Various test such as blood tests, hearing test, critical congenital heart disease (CCHD) tests are performed that provides early detection, diagnosis, intervention which in turn can prevent death or disability. In addition, it helps the baby to live a normal life.

Raising awareness about newborn screening test and benefits associated with same is expected to fuel the newborn screening market growth over the forecast period. Technological innovations in the testing methods is expected to propel the market growth. Rising government initiatives to promote newborn screening is expected to support the market growth. However, lack of trained professional is limiting growth factor for global newborn screening market.

Based on test type, the market is segment based on dry blood spot test, critical congenital heart disease (CCHD) test and hearing screen test. The dry blood spot test is expected to witness rapid growth rate over the forecast period owing to the technological advancements and new product launches.

Based on technology, the market is segmented based on tandem mass spectrometry, pulse oximetry, enzyme and immunoassays, DNA assay, electrophoresis, and hearing screen. Tandem mass spectrometry segment contributes major market share owing to the technological advancement by manufacturers and cost and time effectiveness.

Do Inquiry of the Report Here:

Based on region, the global newborn screening market is segmented into North America, Europe, Latin America, Asia Pacific and Middle East and Africa. North America contributes major market share and expected to maintain its dominance over the forecast period owing to well-developed health infrastructure and favorable government initiatives. Asia Pacific is expected to witness rapid growth rate over the forecast period. This is attributed to increasing government support and investment by leading market players in the region.

Some prominent players in the global newborn screening market are Agilent Technologies, AB Sciex LLC, Medtronic Plc, PerkinElmer Inc., Bio-Rad Laboratories, Inc., GE Life Sciences, Masimo Corporation, Natus Medical Incorporated, Trivitron Healthcare, and Waters Corporation.


Leave a Reply

Your email address will not be published. Required fields are marked *

%d bloggers like this: